Pfizer’s Global Medical Grants group awarded a $250,000 grant to the prominent health system in the Detroit metropolitan area, Henry Ford Cancer Institute, to reduce prostate cancer disparities among Black men. Overseen by the American Cancer Society, this grant is part of a series of grants and supports across the nation seeking to reduce health inequity. Black males face higher risks of developing and dying from prostate cancer. Meanwhile, Henry Ford Health System recently launched a program, funded by Genentech (Roche) to improve Black and other minorities' rate of participation in clinical research.
Apparently, the demand for these funds was intense and the competition fierce as each grant applicant needed to demonstrate solutions to local problems across the cancer continuum. Pfizer and the American Cancer Society awarded grants to health systems in Massachusetts, Georgia, Washington DC and Pennsylvania. Henry Ford health System was the only grant award winner in Michigan.
“Black men tend to develop prostate cancer at a younger age, have more advanced disease when diagnosed, and are twice as likely to die from prostate cancer vers...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).